Leishmaniasis — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Visceral leishmaniasis treated with specialist-directed liposomal amphotericin B
The best answer is “Visceral leishmaniasis treated with specialist-directed liposomal amphotericin B”. The reticuloendothelial syndrome and intracellular amastigotes identify visceral leishmaniasis; liposomal amphotericin B is preferred in UK specialist practice, with schedule modified for host factors. Species, geography, lesion burden, immune status and mucosal risk determine whether cutaneous leishmaniasis needs local or systemic treatment.
Reference: WHO leishmaniasis fact sheet: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis